Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections

被引：0
|
作者：
Pamela A. Moise-Broder
Alan Forrest
Mary C. Birmingham
Jerome J. Schentag
机构：
[1] LLC,CPL Associates
[2] University at Buffalo School of Pharmacy and Pharmaceutical Sciences,undefined
来源：
Clinical Pharmacokinetics | 2004年 / 43卷
关键词：
Minimum Inhibitory Concentration; Vancomycin; Lower Respiratory Tract Infection; Bacterial Eradication; Vancomycin Dosage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：925 / 942
页数：17
相关论文
共 50 条
  • [21] Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model
    Lubenko, Irene Yu.
    Strukova, Elena V.
    Smirnova, Maria V.
    Vostrov, Sergey N.
    Portnoy, Yury A.
    Zinner, Stephen H.
    Firsov, Alexander A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 1065 - 1069
  • [22] Pharmacokinetics of Vancomycin in patients with Methicillin Resistant Staphylococcus aureus (MRSA) Infections
    Krishnappa, Niveditha
    Natarajan, Harivenkatesh
    Sistla, Sujatha
    Sistla, Sarath Chandra
    Vivekanandan, M.
    Girish, C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 351 - 355
  • [23] Pharmacoeconomic analysis of Staphylococcus aureus lower respiratory tract infections:: Correlation of AUIC24 and cost of care
    Moise, PA
    Paladino, JA
    Forrest, A
    Birmingham, MC
    Schentag, JJ
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 290 - 290
  • [24] Optimal vancomycin serum level in Staphylococcus aureus infections
    Bingen, E.
    Mariani-Kurkdjian, P.
    Nebbad, B.
    MEDECINE ET MALADIES INFECTIEUSES, 2006, 36 (09): : 439 - 442
  • [25] VANCOMYCIN PROTEIN-BINDING IN PATIENTS WITH INFECTIONS CAUSED BY STAPHYLOCOCCUS-AUREUS
    ALBRECHT, LM
    RYBAK, MJ
    WARBASSE, LH
    EDWARDS, DJ
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (7-8): : 713 - 715
  • [26] METHICILIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) RESPIRATORY TRACT INFECTIONS IN ICU PATIENTS: LACK OF INFLUENCE OF REDUCED SUSCEPTIBILITY TO VANCOMYCIN (VA) AND LINEZOLID (LZD) ON OUTCOME
    Tolon Herrera, M. J.
    Riesco de Vega, L.
    Jimenez Martin, M. J.
    Domingo Marin, S.
    Parro Herrero, L.
    De la Torre Ramos, M. A.
    Fernandez Munoz, R.
    Sanchez Garcia, M.
    Bonilla Hernandez, I.
    Andrade, R.
    INTENSIVE CARE MEDICINE, 2009, 35 : 200 - 200
  • [27] Pharmacokinetics of Vancomycin in Extremely Obese Patients with Suspected or Confirmed Staphylococcus aureus Infections
    Adane, Eyob D.
    Herald, Michael
    Koura, Firas
    PHARMACOTHERAPY, 2015, 35 (02): : 127 - 139
  • [28] Lower Respiratory Tract Infections
    Carroll, Karen C.
    Adams, La'tonzia L.
    MICROBIOLOGY SPECTRUM, 2016, 4 (04):
  • [29] Lower respiratory tract infections
    Porras, ON
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 : 36 - 40
  • [30] Prediction of Vancomycin Pharmacodynamics in Children With Invasive Methicillin-Resistant Staphylococcus aureus Infections: A Monte Carlo Simulation
    Frymoyer, Adam
    Hersh, Adam L.
    Coralic, Zlatan
    Benet, Leslie Z.
    Guglielmo, B. Joseph
    CLINICAL THERAPEUTICS, 2010, 32 (03) : 534 - 542
12345